✦ LIBER ✦

Potent, Orally Bioavailable Delta Opioid Receptor Agonists for the Treatment of Pain: Discovery of N , N -Diethyl-4-(5-hydroxyspiro[chromene-2,4′-piperidine]-4-yl)benzamide (ADL5859)

✍ Scribed by Bourdonnec, Bertrand Le; Windh, Rolf T.; Ajello, Christopher W.; Leister, Lara K.; Gu, Minghua; Chu, Guo-Hua; Tuthill, Paul A.; Barker, William M.; Koblish, Michael; Wiant, Daniel D.; Graczyk, Thomas M.; Belanger, Serge; Cassel, Joel A.; Feschenko, Marina S.; Brogdon, Bernice L.; Smith, Steven A.; Christ, David D.; Derelanko, Michael J.; Kutz, Steve; Little, Patrick J.; DeHaven, Robert N.; DeHaven-Hudkins, Diane L.; Dolle, Roland E.

Book ID: 120003393
Publisher: American Chemical Society
Year: 2008
Tongue: English
Weight: 125 KB
Volume: 51
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm8008986

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery of 2-[(2,4-Dichlorophenyl)amin

Discovery of 2-[(2,4-Dichlorophenyl)amino]- N -[(tetrahydro- 2 H -pyran-4-yl)methyl]-4-(trifluoromethyl)- 5-pyrimidinecarboxamide, a Selective CB2 Receptor Agonist for the Treatment of Inflammatory Pain

✍ Giblin, Gerard M. P.; O'Shaughnessy, Celestine T.; Naylor, Alan; Mitchell, Willi 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 53 KB

Potent, Orally Bioavailable Calcitonin G

Potent, Orally Bioavailable Calcitonin Gene-Related Peptide Receptor Antagonists for the Treatment of Migraine: Discovery of N -[(3 R ,6 S )-6-(2,3-Difluorophenyl)-2-oxo-1- (2,2,2-trifluoroethyl)azepan-3-yl]-4- (2-oxo-2,3-dihydro-1 H -imidazo[4,5- b ]pyridin- 1-yl)piperidine-1-carboxamide (MK-0974)

✍ Paone, Daniel V.; Shaw, Anthony W.; Nguyen, Diem N.; Burgey, Christopher S.; Den 📂 Article 📅 2007 🏛 American Chemical Society 🌐 English ⚖ 54 KB

Discovery of N-benzyl-2-[(4S)-4-(1H-indo

Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesity

✍ Richard L. Elliott; Kimberly O. Cameron; Janice E. Chin; Jeremy A. Bartlett; Ele 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 598 KB

We describe the design, synthesis, and structure-activity relationships of triazolobenzodiazepinone CCK1 receptor agonists. Analogs in this series demonstrate potent agonist activity as measured by in vitro and in vivo assays for CCK1 agonism. Our efforts resulted in the identification of compound 4

ChemInform Abstract: Discovery of N-Benz

ChemInform Abstract: Discovery of N-Benzyl-2- [(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H- [1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide (I), an Orally Active, Gut-Selective CCK1 Receptor Agonist for the Potential Treatment of Obesity.

✍ Kimberly O. Cameron; et al. et al. 📂 Article 📅 2011 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

Discovery of 5-(2-amino-[1,2,4]triazolo[

Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease

✍ Mihiro Sunose; Kathryn Bell; Katie Ellard; Giovanna Bergamini; Gitte Neubauer; T 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 604 KB

ChemInform Abstract: Discovery of 5-(2-A

ChemInform Abstract: Discovery of 5-(2-Amino-[1,2,4]triazolo [1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a Potent, Orally Bioavailable and Selective Inhibitor of PI3K for the Treatment of Inflammatory Disease.

✍ Sunose, Mihiro; Bell, Kathryn; Ellard, Katie; Bergamini, Giovanna; Neubauer, Git 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 23 KB